Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Publication Type:
Journal Article
Authors:
Kwo, Paul Y.;
Poordad, Fred;
Asatryan, Armen;
Wang, Stanley;
Wyles, David L.;
Hassanein, Tarek;
Felizarta, Franco;
Sulkowski, Mark S.;
Gane, Edward;
Maliakkal, Benedict;
Overcash, J. Scott;
Gordon, Stuart C.;
Muir, Andrew J.;
Aguilar, Humberto;
Agarwal, Kosh;
Dore, Gregory J.;
Lin, Chih-Wei;
Liu, Ran;
Lovell, Sandra S.;
Ng, Teresa I.;
Kort, Jens;
Mensa, Federico J.Source:
J Hepatol, Volume 67, Issue 2, p.263-271 (2017)
Keywords:
ABT-493,
ABT-530,
D-alanine transaminase,
Direct-Acting Antiviral,
Genotype,
Hepatitis C, Chronic,
Interferons,
Liver Cirrhosis,
Pangenotypic,
SURVEYOR,
sustained virologic response
